» Authors » Federico Perdomo-Celis

Federico Perdomo-Celis

Explore the profile of Federico Perdomo-Celis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 401
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Castro-Trujillo S, Mejia W, Segura K, Castro-Meneses J, Vega R, Salgado D, et al.
PLoS Negl Trop Dis . 2025 Jan; 19(1):e0012193. PMID: 39761322
Background: Gestational Zika virus (ZIKV) infection is associated with the development of congenital Zika syndrome (CZS), which includes microcephaly and fetal demise. The magnitude and quality of orthoflavivirus-specific humoral immunity...
2.
Saez-Cirion A, Mamez A, Avettand-Fenoel V, Nabergoj M, Passaes C, Thoueille P, et al.
Nat Med . 2024 Sep; 30(12):3544-3554. PMID: 39222660
HIV cure has been reported for five individuals who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) with cells from CCR5Δ32 homozygous donors. By contrast, viral rebound has occurred in other...
3.
Gutierrez-Barbosa H, Medina-Moreno S, Perdomo-Celis F, Davis H, Chua J, Zapata J
Pathogens . 2024 Aug; 13(8). PMID: 39204240
Dengue is a significant public health problem with no specific viral treatment. One of the main challenges in studying dengue is the lack of adequate animal models recapitulating human immune...
4.
Montenegro C, Perdomo-Celis F, Franco M
Viruses . 2024 Jun; 16(6). PMID: 38932111
Rotavirus infection continues to be a significant public health problem in developing countries, despite the availability of several vaccines. The efficacy of oral rotavirus vaccines in young children may be...
5.
Passaes C, Desjardins D, Chapel A, Monceaux V, Lemaitre J, Melard A, et al.
Nat Commun . 2024 Jan; 15(1):178. PMID: 38212337
HIV remission can be achieved in some people, called post-treatment HIV controllers, after antiretroviral treatment discontinuation. Treatment initiation close to the time of infection was suggested to favor post-treatment control,...
6.
Salgado D, Silva J, Salcedo A, Losada P, Nino A, Molano M, et al.
Pediatr Infect Dis J . 2023 Nov; 43(2):123-129. PMID: 37930223
Background: Secondary bacterial infection (SBI) occurs in a proportion of individuals with dengue and results in longer hospitalization, higher mortality, and increased health-related costs. However, the frequency, risk factors and...
7.
Cabral-Piccin M, Briceno O, Papagno L, Liouville B, White E, Perdomo-Celis F, et al.
AIDS . 2023 Oct; 38(2):161-166. PMID: 37800637
Background: The induction of de novo CD8 + T-cell responses is essential for protective antiviral immunity, but this process is often impaired in people with HIV-1 (PWH). We investigated the...
8.
Martel F, Cuervo-Rojas J, Angel J, Ariza B, Gonzalez J, Ramirez-Santana C, et al.
Front Immunol . 2023 Sep; 14:1274753. PMID: 37662943
[This corrects the article DOI: 10.3389/fimmu.2023.1241038.].
9.
Martel F, Cuervo-Rojas J, Angel J, Ariza B, Gonzalez J, Ramirez-Santana C, et al.
Front Immunol . 2023 Aug; 14:1241038. PMID: 37575243
The SARS CoV-2 antibody and CD4 T cell responses induced by natural infection and/or vaccination decline over time and cross-recognize other viral variants at different levels. However, there are few...
10.
Salgado D, Rivera G, Pinto W, Rodriguez J, Acosta G, Castaneda D, et al.
Pediatr Infect Dis J . 2023 Jul; 42(9):792-800. PMID: 37463399
Background: Pediatric dengue and sepsis share clinical and pathophysiologic aspects. Multiple inflammatory and regulatory cytokines, decoy receptors and vascular permeability factors have been implicated in the pathogenesis of both diseases....